vs
REPLIGEN CORP（RGEN）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是RESOURCES CONNECTION, INC.的1.7倍（$197.9M vs $117.7M），REPLIGEN CORP净利率更高（6.7% vs -10.8%，领先17.5%），REPLIGEN CORP同比增速更快（13.6% vs -19.2%），REPLIGEN CORP自由现金流更多（$17.6M vs $15.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -11.8%）
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
RGEN vs RGP — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$117.7M
营收增速更快
RGEN
高出32.8%
-19.2%
净利率更高
RGEN
高出17.5%
-10.8%
自由现金流更多
RGEN
多$2.0M
$15.6M
两年增速更快
RGEN
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $197.9M | $117.7M |
| 净利润 | $13.3M | $-12.7M |
| 毛利率 | 52.5% | 37.1% |
| 营业利润率 | 9.0% | -10.3% |
| 净利率 | 6.7% | -10.8% |
| 营收同比 | 13.6% | -19.2% |
| 净利润同比 | 143.9% | 81.6% |
| 每股收益（稀释后） | $0.24 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RGENRGP
| Q4 25 | $197.9M | $117.7M | ||
| Q3 25 | $188.8M | $120.2M | ||
| Q2 25 | $182.4M | $139.3M | ||
| Q1 25 | $169.2M | $129.4M | ||
| Q4 24 | $174.1M | $145.6M | ||
| Q3 24 | $154.9M | $136.9M | ||
| Q2 24 | $154.1M | $148.2M | ||
| Q1 24 | $151.3M | $151.3M |
净利润RGENRGP
| Q4 25 | $13.3M | $-12.7M | ||
| Q3 25 | $14.9M | $-2.4M | ||
| Q2 25 | $14.9M | $-73.3M | ||
| Q1 25 | $5.8M | $-44.1M | ||
| Q4 24 | $-30.3M | $-68.7M | ||
| Q3 24 | $-654.0K | $-5.7M | ||
| Q2 24 | $3.3M | $10.5M | ||
| Q1 24 | $2.1M | $2.5M |
毛利率RGENRGP
| Q4 25 | 52.5% | 37.1% | ||
| Q3 25 | 53.2% | 39.5% | ||
| Q2 25 | 50.0% | 40.2% | ||
| Q1 25 | 53.6% | 35.1% | ||
| Q4 24 | 26.1% | 38.5% | ||
| Q3 24 | 50.0% | 36.5% | ||
| Q2 24 | 49.8% | 40.2% | ||
| Q1 24 | 49.5% | 37.0% |
营业利润率RGENRGP
| Q4 25 | 9.0% | -10.3% | ||
| Q3 25 | 8.9% | -1.7% | ||
| Q2 25 | 7.6% | -47.0% | ||
| Q1 25 | 3.9% | -38.4% | ||
| Q4 24 | -17.7% | -52.7% | ||
| Q3 24 | -5.1% | -3.5% | ||
| Q2 24 | 1.0% | 7.6% | ||
| Q1 24 | 1.3% | 2.8% |
净利率RGENRGP
| Q4 25 | 6.7% | -10.8% | ||
| Q3 25 | 7.9% | -2.0% | ||
| Q2 25 | 8.2% | -52.6% | ||
| Q1 25 | 3.4% | -34.0% | ||
| Q4 24 | -17.4% | -47.2% | ||
| Q3 24 | -0.4% | -4.2% | ||
| Q2 24 | 2.2% | 7.1% | ||
| Q1 24 | 1.4% | 1.7% |
每股收益（稀释后）RGENRGP
| Q4 25 | $0.24 | $-0.38 | ||
| Q3 25 | $0.26 | $-0.07 | ||
| Q2 25 | $0.26 | $-2.21 | ||
| Q1 25 | $0.10 | $-1.34 | ||
| Q4 24 | $-0.55 | $-2.08 | ||
| Q3 24 | $-0.01 | $-0.17 | ||
| Q2 24 | $0.06 | $0.31 | ||
| Q1 24 | $0.04 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $767.6M | $89.8M |
| 总债务越低越好 | $542.2M | — |
| 股东权益账面价值 | $2.1B | $194.6M |
| 总资产 | $2.9B | $289.3M |
| 负债/权益比越低杠杆越低 | 0.26× | — |
8季度趋势，按日历期对齐
现金及短期投资RGENRGP
| Q4 25 | $767.6M | $89.8M | ||
| Q3 25 | $748.7M | $77.5M | ||
| Q2 25 | $708.9M | $86.1M | ||
| Q1 25 | $697.2M | $72.5M | ||
| Q4 24 | $757.4M | $78.2M | ||
| Q3 24 | $784.0M | $89.6M | ||
| Q2 24 | $809.1M | $108.9M | ||
| Q1 24 | $780.6M | $113.8M |
总债务RGENRGP
| Q4 25 | $542.2M | — | ||
| Q3 25 | $537.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $525.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益RGENRGP
| Q4 25 | $2.1B | $194.6M | ||
| Q3 25 | $2.1B | $206.4M | ||
| Q2 25 | $2.1B | $207.1M | ||
| Q1 25 | $2.0B | $277.8M | ||
| Q4 24 | $2.0B | $325.7M | ||
| Q3 24 | $2.0B | $407.2M | ||
| Q2 24 | $2.0B | $418.8M | ||
| Q1 24 | $2.0B | $414.9M |
总资产RGENRGP
| Q4 25 | $2.9B | $289.3M | ||
| Q3 25 | $2.9B | $287.2M | ||
| Q2 25 | $2.9B | $304.7M | ||
| Q1 25 | $2.9B | $375.6M | ||
| Q4 24 | $2.8B | $424.9M | ||
| Q3 24 | $2.8B | $512.9M | ||
| Q2 24 | $2.9B | $510.9M | ||
| Q1 24 | $2.8B | $523.2M |
负债/权益比RGENRGP
| Q4 25 | 0.26× | — | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.7M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $17.6M | $15.6M |
| 自由现金流率自由现金流/营收 | 8.9% | 13.2% |
| 资本支出强度资本支出/营收 | 4.1% | 0.3% |
| 现金转化率经营现金流/净利润 | 1.93× | — |
| 过去12个月自由现金流最近4个季度 | $93.9M | $24.3M |
8季度趋势，按日历期对齐
经营现金流RGENRGP
| Q4 25 | $25.7M | $15.9M | ||
| Q3 25 | $48.1M | $-7.8M | ||
| Q2 25 | $28.6M | $16.8M | ||
| Q1 25 | $15.0M | $659.0K | ||
| Q4 24 | $39.2M | $1.8M | ||
| Q3 24 | $49.3M | $-309.0K | ||
| Q2 24 | $42.2M | $3.2M | ||
| Q1 24 | $44.7M | $20.5M |
自由现金流RGENRGP
| Q4 25 | $17.6M | $15.6M | ||
| Q3 25 | $43.4M | $-8.0M | ||
| Q2 25 | $21.5M | $16.5M | ||
| Q1 25 | $11.4M | $238.0K | ||
| Q4 24 | $33.6M | $61.0K | ||
| Q3 24 | $42.3M | $-575.0K | ||
| Q2 24 | $37.4M | $3.0M | ||
| Q1 24 | $36.4M | $20.4M |
自由现金流率RGENRGP
| Q4 25 | 8.9% | 13.2% | ||
| Q3 25 | 23.0% | -6.6% | ||
| Q2 25 | 11.8% | 11.8% | ||
| Q1 25 | 6.8% | 0.2% | ||
| Q4 24 | 19.3% | 0.0% | ||
| Q3 24 | 27.3% | -0.4% | ||
| Q2 24 | 24.3% | 2.1% | ||
| Q1 24 | 24.0% | 13.5% |
资本支出强度RGENRGP
| Q4 25 | 4.1% | 0.3% | ||
| Q3 25 | 2.5% | 0.1% | ||
| Q2 25 | 3.9% | 0.2% | ||
| Q1 25 | 2.1% | 0.3% | ||
| Q4 24 | 3.2% | 1.2% | ||
| Q3 24 | 4.5% | 0.2% | ||
| Q2 24 | 3.1% | 0.1% | ||
| Q1 24 | 5.5% | 0.1% |
现金转化率RGENRGP
| Q4 25 | 1.93× | — | ||
| Q3 25 | 3.23× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.57× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 12.70× | 0.30× | ||
| Q1 24 | 21.35× | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RGEN
暂无分部数据
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
